In line with the research goal of our group, i.e., to find active molecules for correction of mitochondrial diseases, we raised the hypothesis that resveratrol could enhance or correct the FAO capacities in CPT2- and VLCAD-deficient fibroblasts [22]. Here, CPT2 is linked to very long chain acyl-CoA dehydrogenase deficiency.